condition may provide prompt early intervention and prevention of this condition in Bangladesh.
Methods:
This cross sectional analytical study was conducted in the Dept. of Hematology and Oncology, Dhaka Medical College Hospital (DMCH) starting from July 2013 to June 2014. Beta thalassemia major patients admitted for blood transfusion were selected as study population. Sampling was done by non-randomized qualitative purposive sampling. A total of 50 patients with beta thalassemia were included in the study on the basis of following selection criteria-children suffering from beta thalassemia major diagnosed by Hb electrophoresis, age in between 4-12 years, received blood transfusion at least 10 times. Patients with other co morbid conditions (DM, ESRD), known case of congenital hypothyroidism, hyperparathyroidism and who are receiving any cardiac medication were excluded from the study.
A structured questionnaire was formed that include all the variables of interest. Their iron status was be assessed by doing serum ferritin level. Echocardiography (SIEMENS ACUSON X500 GERMANY) was performed in Paediatric cardiology department, National Institute of Cardiovascular Diseases, Dhaka. Conventional echocardiographic measurements were done according to the American Society of Echocardiography guidelines. 5 From the parasternal long-axis view of the LV end-diastolic and end-systolic diameters, interventricular septal and posterior wall thicknesses were expressed in millimeters. We measured LV end-systolic and end-diastolic (EDV) volumes from the apical 4-chamber view. Left ventricle fractional shortening (FS) and ejection fraction (EF) were measured using the Teichholz formula. LV filling was evaluated by pulse wave Doppler from the apical 4-chamber view with the sample volume position at the tips of the mitral valve, and velocities in early (E) and late (A) diastole were recorded, in addition to the calculation of the E/A ratio. 
Ethics
Written informed consent was taken from each patient before data collection. Confidentiality was strictly maintained and the patients were informed about the study and their rights to withdraw at any stage which would not hamper the rights to treatments. The study protocol was approved by the institutional review board of DMCH, Dhaka.
Results:
A total of 50 patients with beta thalassemia were available for analysis. The mean age of the study sample was 7.7±3.1. Most of the subjects belong to 6-10 years (50%) and 34% of patients were male. Of the 50 children with thalassemia 58% had their siblings affected. The mean age at diagnosis and at transfusion was 4.35 years. The average time interval between two consecutive transfusions was 4.3 months. About 20% children used chelating agent. The mean duration of transfusion was almost 6 years and the average number of transfusions was 23. The average serum ferritin level was 1280 ng/ml. [ Table I ] 
Discussion
The present study showed that cardiac dysfunction was present in 11 patients; systolic cardiac dysfunction present in 7(14%) of patients and diastolic dysfunction present in 4(8%) of patients, with high incidence in patients with low pre transfusional haemoglobin group (p=0.4). Anaemia is a contributing factor for cardiac dysfunction in thalassaemic patients, abnormal cardiac function was higher in patients with anaemia of moderate severity, and although statistically not significant it indicates a positive correlation between severity of anaemia and cardiac dysfunction. This finding is consisted with Kremastinos et al. 6 Cardiac dysfunction occurring more frequently in patients having high serum ferritin level (p=0.02). This findings supported by several other similarly designed studies conducted by Shikow et al, 7 Bosi et al, 8 Noori et al. 9 Quality and duration of life of thalassaemic patients can be expected now to extend beyond the 3rd decade with regular blood transfusion and iron chelating therapy. Cardiac complications is still a major problem in the management of these patients as a consequence of chronic iron overload can result from transfusional iron overload, increased intestinal absorption of iron and also from ineffective erythropoiesis. 10 Within the heart, changes Among all the hematological data considered, only the serum ferritin concentration showed a weak negative correlation with the left ventricular ejection fraction (r = -0.22; p < 0.05) [ Figure 1 ] associated with chronic anaemia which is aggravated by iron deposition. Excessive iron deposition associated with cardiac hypertrophy and dilatation, degeneration of myocardial fibers and in rare cases fibrosis. In patients who are receiving transfusion but not chelating therapy symptomatic cardiac disease has been reported within 10 years after the start of transfusion. [11] [12] [13] In our study, we found a weak but significant correlation between left ventricular ejection fraction and serum ferritin concentration (r=-0.22; p=0.03). Patients with a high ferritin concentration (> 1000 ng/ml) had a lower ejection fraction than patients with a low ferritin concentration (< 1000 ng/ml). In 1994 Olivieri and colleagues, in a prospective clinical study, found that the cardiovascular prognosis in thalassaemic patients was excellent if serum ferritin concentrations were maintained below 2500 ng/ml. This value has been considered a "safe" concentration. 14 Our study confirms this assumption, demonstrating the importance of a low ferritin concentration for the preservation of left ventricular mechanics. This probably reflects a more aggressive treatment and the further lowering of the ferritin concentration in our study population. Our study suggests that a serum ferritin value of less than 1000 ng/ml should be considered the ideal goal of any therapeutic schedule and in 2003 Bosi and colleagues also reported this. 8 Reports concerning left ventricular diastolic function in patients with beta thalassemia are somewhat normal. Only few patients had diastolic dysfunction. In 1991, Spirito and colleagues reported a restrictive pattern of trans-mitral flow in a group of young adults with normal systolic function. 9 In contrast, no alteration in left ventricular compliance was reported in the early stage of the disease by Kremastinos and associates. 10, 15 In agreement with Kremastinos and colleagues, 10 we have shown in our group of asymptomatic thalassaemic children that there is normal left ventricular compliance.
Limitation of the study
However, like other scientific study this present study is not without limitation.The present study was conducted on a small number of cases and as such the study findings cannot be generalized to reference population.Analysis of left ventricular diastolic function assessed diastolic filling which is not always equivalent todiastolic function. Number of blood units transfused has not been shown conclusively to be an accurate index of iron overload, since iron turnover and iron absorption are increased in beta thalassemia major, and in addition, iron chelation therapy decreases the amount of deposited iron. Serum ferritin cannot accurately estimate the iron content is higher in the heart.
Conclusion:
This is the first study to present the cardiac dysfunction related to repeated transfusion among beta Thalassaemia patients in Bangladesh. Patients with beta thalassaemia on an adequate transfusion showed an abnormal left ventricular systolic and diastolic dysfunction which is mainly related to chronic anaemia and serum ferritin level. It may be recommended that echo1cardiographic assessment should be routinely done in beta thalassaemia patient on transfusion specially those with serum ferritin concentration more than 1000 ng/ml. Standard chelation treatment should be given to preserve cardiac and other vital organ function.
